your market intelligence analyst
Search Results
295 results
Your search is now limited to «GlaxoSmithKline» expert search.
Daily Excelsior (India) 07/22/2019 14:27
The company had posted a net profit of Rs 84.08 crore for the corresponding period previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing.
More from Daily Excelsior (India):
ENDPOINTS 07/22/2019 09:27
Just ahead of GlaxoSmithKline’s Q2 update on Wednesday, science chief Hal Barron is making the rounds to talk up the pharma giant’s late-stage strategy as the top execs continue to woo back a deeply skeptical investor group while pushing through a whole new R&D culture ...
More from ENDPOINTS:
FierceMedicalDevices 07/22/2019 05:24
Hal Barron has detailed efforts to embolden GlaxoSmithKline scientists to take “smart risks” when developing drugs.
More from FierceMedicalDevices: 07/19/2019 06:56
The burden is, however, expected to remain significant until vaccination is available.
More from 07/19/2019 01:34
Global Allergy Rhinitis Drugs Market report is first of its kind research report that incorporates the overview, summary, market dynamics, competitive analysis, and leading player’s various strategies to sustain in the worldwide market.
More from
GlaxoSmithKline (GSK) said that a phase 3 trial evaluating its polymerase (PARP) inhibitor Zejula (niraparib) as a maintenance therapy for first-line ovarian cancer following platinum-based chemotherapy, has met its primary endpoint.
More from Pharmaceutical Business Review: 07/16/2019 12:36
GSK's two-drug HIV Dovato treatment meets main goal in study.
More from
Pharmafile 07/16/2019 04:26
GlaxoSmithKline has teamed up with the University of Nottingham and the University of Strathclyde for a five-year partnership aimed at promoting new medical research.
More from Pharmafile:
PR Newswire 07/15/2019 17:24
To simplify vaccine storage and procurement and to help healthcare professionals realize every appropriate vaccination opportunity, GSK offers two influenza vaccines with the same vaccine dose for all recommended patients.
More from PR Newswire:
GlaxoSmithKline has hailed a major step forward for an ovarian cancer drug it acquired last year, announcing that it has been effective in stopping the spread of ovarian cancer.
More from Scotland Herald (United Kingdom):
pharmaphorum 07/15/2019 12:29
GlaxoSmithKline is reported to have found the person it wants to replace Sir Philip Hampton as its non-executive chairman, going for someone with plenty of pharma industry experience.
More from pharmaphorum:
BioPharma Dive 07/15/2019 11:51
Topline results from the Phase 3 PRIMA study show GSK's Zejula, which inhibits a DNA repair enzyme called PARP, significantly improved progression free survival over placebo when used as a first-line maintenance treatment following platinum-based chemotherapy.
More from BioPharma Dive:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications